IL-8 and the innate immunity as biomarkers in acute child and adolescent psychopathology

Psychoneuroendocrinology

Volumn 62, Issue , 2015, Pages 233-242

  Gariup, Maria ^a,b   Gonzalez, Azucena ^c   Lázaro, Luisa ^b,c,d   Torres, Ferran ^d,e   Serra Pagès, Carles ^b,c,d   Morer, Astrid ^c,d  

^a KOLDING HOSPITAL   (Denmark)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Child and adolescent psychiatry; Cytokines; IL 8; Inflammation; Psychoneuroimmunology; Stress

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

ADJUSTMENT DISORDER; ADOLESCENT DISEASE; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; BODY MASS; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DRUG USE; FAMILY LIFE; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; INNATE IMMUNITY; LIFE EVENTS SCALE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL STRESS; MONOCYTE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOSIS; SEX DIFFERENCE; ADOLESCENT; BLOOD; IMMUNOLOGY; INFLAMMATION; PHYSIOLOGY;

ADOLESCENT; BIOMARKERS; CHILD; CYTOKINES; FEMALE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-8; MALE; MENTAL DISORDERS;

EID: 84947443372     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2015.08.017     Document Type: Article

References (50)

1. Andrade C. Nonsteroidal anti-inflammatory drugs and 5-HT[U+2083] serotonin receptor antagonists as innovative antipsychotic augmentation treatments for schizophrenia. J. Clin. Psychiatry 2014, 75(7):e707-e709. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25093487 (accessed 10.11.14.).
2. Benes F.M. Myelination of cortical-hippocampal relays during late adolescence. Schizophr. Bull. 1989, 15(4):585-593. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2623440 (accessed 10.03.14.).
3. Bergink V., Gibney S.M., Drexhage H.A. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol. Psychiatry 2014, 75(4):324-331. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24286760 (accessed 07.10.14.).
4. Beumer W., et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 2012, 92(5):959-975. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22875882 (accessed 09.27.14.).
5. Chrousos G.P., Kino T. Ikaros transcription factors: flying between stress and inflammation. J. Clin. Invest. 2005, 115(4):844-848.
6. Coelho R., et al. Childhood maltreatment and inflammatory markers: a systematic review. Acta Psychiatrica Scand. 2014, 129(3):180-192. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24205846 (accessed 08.17.14.).
7. Cross-Disorder Group of the Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381(9875):1371-1379. Available at: http://www.thelancet.com/article/S0140673612621291/fulltext (accessed 07.10.14.).
8. Danese A., et al. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch. Gen. Psychiatry 2008, 65(4):409-415. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2923056&tool=pmcentrez&rendertype=abstract (accessed 08.23.14.).
9. Dennison U., et al. Schizophrenia patients with a history of childhood trauma have a pro-inflammatory phenotype. Psychol. Med. 2012, 42(9):1865-1871. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22357348 (accessed 08.18.14.).
10. Doherty J.L., Owen M.J. Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med. 2014, 6(4):29. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4062063&tool=pmcentrez&rendertype=abstract (accessed 07.14.14.).
11. Dowlati Y., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67(5):446-457. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20015486 (accessed 07.11.14.).
12. Dutheil F., et al. Urinary interleukin-8 is a biomarker of stress in emergency physicians, especially with advancing age-the JOBSTRESS* randomized trial. PLoS One 2013, 8(8):e71658. 8,e71658. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3747272&tool=pmcentrez&rendertype=abstract (accessed 02.14.15.).
13. Eyre H., Baune B.T. Neuroimmunological effects of physical exercise in depression. Brain Behav. Immun. 2012, 26(2):251-266. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21986304 (accessed 10.04.14.).
14. Fagundes C.P., Glaser R., Kiecolt-Glaser J.K. Stressful early life experiences and immune dysregulation across the lifespan. Brain Behav. Immun. 2013, 27:8-12.
15. Feigenson K.A., Kusnecov A.W., Silverstein S.M. Inflammation and the two-hit hypothesis of schizophrenia. Neurosci. Biobehav. Rev. 2014, 38:72-93. Available at: http://www.sciencedirect.com/science/article/pii/S0149763413002753 (accessed 08.12.14.).
16. Felger J.C., Lotrich F.E. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013, 246:199-229. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23644052 (accessed 07.09.14.).
17. Gluckman P.D., et al. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 2008, 359(1):61-73. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3923653&tool=pmcentrez&rendertype=abstract (accessed 09.5.14.).
18. Gray S.M., Bloch M.H. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr. Psychiatry Rep. 2012, 14(3):220-228. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3625952&tool=pmcentrez&rendertype=abstract (accessed 12.27.14.).
19. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
20. Insel T.R. The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry. Am. J. Psychiatry 2014, 171(4):395-397. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24687194.
21. Jones K.A., Thomsen C. The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci. 2013, 53:52-62. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23064447 (accessed 08.13.14.).
22. Kapur S., Phillips A.G., Insel T.R. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?. Mol. Psychiatry 2012, 17(12):1174-1179. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22869033 (accessed 07.16.14.).
23. Lepore L., et al. Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin. Exp. Rheumatol. 1994, 12(5):561-565. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7531125.
24. Lin P.Y., et al. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry 2007, 68:1056-1061.
25. Lotrich F.E. Inflammatory cytokine-associated depression. Brain Res. 2014, Available at: http://www.ncbi.nlm.nih.gov/pubmed/25003554 (accessed 11.22.14.).
26. Masi A., et al. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol. psychiatry 2014, (April):1-7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24934179 (accessed 08.13.14.).
27. Miller A.H., et al. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 2013, 30(4):297-306. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23468190 (accessed 08.13.14.).
28. Miller B.J., et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70(7):663-671. Available at: http://www.sciencedirect.com/science/article/pii/S0006322311004045 (accessed 08.10.14.).
29. Miller G.E., Chen E. Harsh family climate in early life presages the emergence of a proinflammatory phenotype in adolescence. Psychol. Sci.: J. Am. Psychol. Soc./APS 2010, 21:848-856.
30. Miller G.E., Chen E., Parker K.J. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol. Bull. 2011, 137(6):959-997. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3202072&tool=pmcentrez&rendertype=abstract (accessed 08.9.14.).
31. Miller G.E., Cole S.W. Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol. Psychiatry 2012, 72(1):34-40. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3493164&tool=pmcentrez&rendertype=abstract (accessed 08.13.14.).
32. Mills N.T., et al. Research Review: The role of cytokines in depression in adolescents: a systematic review. J. Child Psychol. Psychiatry 2013, 54(8):816-835. Available at: http://doi.wiley.com/10.1111/jcpp.12080 (accessed 08.10.14).
33. Mitchell R.H.B., Goldstein B.I. Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J. Am. Acad. Child Adolesc. Psychiatry 2014, 53(3):274-296. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24565356 (accessed 08.11.14.).
34. Modabbernia A., et al. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 2013, 74(1):15-25. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23419545 (accessed 08.13.14.).
35. Müller N., et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 2006, 11:680-684.
36. Nanni V., Uher R., Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am. J. Psychiatry 2012, 169(2):141-151. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22420036 (accessed 10.5.14.).
37. Nemets H., et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am. J. Psychiatry 2006, 163(6):1098-1100. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16741212 (accessed 03.16.15.).
38. O'Connor T.G., Moynihan J.A., Caserta M.T. Annual research review: The neuroinflammation hypothesis for stress and psychopathology in children?developmental psychoneuroimmunology. J. Child Psychol. Psychiatry Allied Disciplines 2014, 55(6):615-631. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24372371 (accessed 09.06.14.).
39. Prahalad S., et al. Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis. Pediatric Rheumatol. Online J. 2008, 6:8. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2430568&tool=pmcentrez&rendertype=abstract (accessed 02.14.15.).
40. Qurashi I., et al. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia. J. Psychopharmacol. (Oxford, England) 2014, 28:707-708. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24646811.
41. Raison C.L., et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013, 70(1):31-41. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4015348&tool=pmcentrez&rendertype=abstract (accessed 10.3.14.).
42. Ratnayake U., et al. Cytokines and the neurodevelopmental basis of mental illness. Frontiers in neuroscience 2013, 7:180. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3797953&tool=pmcentrez&rendertype=abstract (accessed 07.22.14.).
43. Shahzad A., et al. Interleukin 8 (IL-8) - a universal biomarker?. International archives of medicine 2010, 3:11. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2893518&tool=pmcentrez&rendertype=abstract (accessed 02.14.15.).
44. Shonkoff J.P., Boyce W.T., McEwen B.S. Neuroscience, molecular biology, and the childhood roots of health disparities: building a new framework for health promotion and disease prevention. JAMA 2009, 301(21):2252-2259. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19491187 (accessed 09.21.14.).
45. Stuart M.J., Baune B.T. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci. Biobehav. Rev. 2014, 42:93-115. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24513303 (accessed 07.25.14.).
46. Tsankova N., et al. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 2007, 8:355-367. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17453016.
47. Tursich M., et al. Association of trauma exposure with proinflammatory activity: a transdiagnostic meta-analysis. Transl. Psychiatry 2014, 4:e413. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4119223&tool=pmcentrez&rendertype=abstract (accessed 09.29.14.).
48. Wieck A., et al. Neuroimmunoendocrine interactions in post-traumatic stress disorder: focus on long-term implications of childhood maltreatment. Neuroimmunomodulation 2014, 21(2-3):145-151. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24557048 (accessed 12.26.14.).
49. Williamson D.E., et al. The stressful life events schedule for children and adolescents: development and validation. Psychiatry Res. 2003, 119(3):225-241. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12914894 (accessed 01.23.15.).
50. Wosu A.C., et al. Correlates of cortisol in human hair: implications for epidemiologic studies on health effects of chronic stress. Ann. Epidemiol. 2013, 23(12):797-811.e2. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3963409&tool=pmcentrez&rendertype=abstract (accessed 01.25.15.).